ONC_AALL08B1

ONC AALL08B1-Classification of Newly Diagnosed Acute Lymphoblastic Leukemia (ALL)

This research trial studies a risk-based classification system for patients with newly diagnosed acute lymphoblastic leukemia. Gathering health information about patients with acute lymphoblastic leukemia may help doctors learn more about the disease and plan the best treatment.

Eligibility: Ages: up to 30 years
DISEASE CHARACTERISTICS:

•Samples from patients registered on the Children Oncology Group (COG)-AALL08B1 protocol and stored in the Hematopathology Laboratory at the University of Washington

◦Pretreatment and after induction therapy samples
PATIENT CHARACTERISTICS:

•Not specified
PRIOR CONCURRENT THERAPY:

•Not specified
N/A
NCT01142427
Cancer
Hematologic
Brenda Wittman, M.D.
COG (Childrens Oncology Group)
Katie Jones
  • Alaska Research
  • Providence Alaska Medical Center